References
- Bernatsky S, Clarke AE, ZahediNiaki O et al (2017) Malignancy in
pediatric-onset systemic lupus erythematosus. J Rheumatol 44(10):
1484-1486. doi: 10.3899/jrheum.170179.
- Ladouceur A, Tessier-Cloutier B, Clarke AE, Ramsey-Goldman R, Gordon
C, Hansen JE, Bernatsky S (2020) Cancer and systemic lupus
erythematosus. Rheum Dis Clin North 46: 533-550. doi:
10.1016/j.rdc.2020.05.005.
- Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y (2018) The risks of cancer
development in systemic lupus erythematosus (SLE) patients: a
systematic review and meta- analysis. Arthritis Res Ther 20: 270.
doi:10.1186/s13075-018-1760-3.
- Lispemeyer EA (1972) Development of malignant cerebral lymphoma in a
patient with systemic lupus erythematosus treated with
immunosuppression. Arthritis Rheum 15: 183-186.
doi:10.1002/art.1780150207.
- Kaulen LD, KarschniaP, Dietrich J, Baehring JM (2020) Autoimmune
disease-related primary CNS lymphoma: systematic review and
meta-analysis. Journal of Neurooncolgy149: (1): 153-159. Doi:
10.1007/s11060-20-03583-9.
- Enblad G, Martinsson G, Baecklund E, Hesselager G, Sundstrom C, Amini
RM, Hagberg H (2017) Population-based experience on primary central
nervous system lymphoma 2000-2012: the incidence is increasing. Acta
Oncol 56(4): 599-607. Doi: 10.1080/0284186X.2016.1270465.
- Ichikawa T, Shimojima Y, Kishida D, Kaneko T, Sekijima Y (2021)
Primary central nervous system lymphoma in neuropsychiatric systemic
lupus erythematosus : case-based review. Rheumatol Int
41(5):1009-1017. Doi: 10.1007/s00296-020-04569-6.
- Bernatsky S, Ramsey-Goldman R, et al. Lymphoma risk in systemic
lupus:effects of disease activity versus treatment. Ann Rheum Dis
2014; 73: 138-142. Doi:10.1136/annrheumdis-2012-202099.
- Drabourg AH, Duus K, Houen G. Epstein-Barr virus in systemic
autoimmune diseases. Clin Dev Immunol 2013; 535738. Doi:
10.1155/2013/535738.